AttendMe Owl Logo
AttendMe
Evidence Evolution
Evidence Evolution
Landmark TrialRCTRandomized Controlled Trial

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

New England Journal of Medicine2010IF: 25.4

The ACCORD Study Group

PMID: 20228401View on PubMedDOI

Abstract

In patients with type 2 diabetes at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, did not reduce the rate of a composite outcome of fatal and nonfatal major cardiovascular events. (ClinicalTrials.gov number, NCT00000620.)

Specialty

Family Medicine

Featured in Evidence Evolutions